Medical Articles 11/20
Posted by rob on November 20, 2007 under Uncategorized | 
Be the First to Comment
Lee SY, Lee MS, Cherla RP, Tesh VL.
Shiga toxin 1 induces apoptosis through the ER stress response in human monocytic cells.
Cell Microbiol. 2007 Nov 13; [Epub ahead of print]
PMID: 18005243 [PubMed - as supplied by publisher]
2:
[Full-length cloning of a novel gene, ELF2C, related to familial acute myelogenous leukemia.]
Zhonghua Yi Xue Za Zhi. 2007 Aug;87(32):2245-2248. Chinese.
PMID: 18001542 [PubMed - as supplied by publisher]
3:
The mystery of chromosomal translocations in cancer.
Cytogenet Genome Res. 2007;118(2-4):247-251.
PMID: 18000377 [PubMed - as supplied by publisher]
4:
Human UMP-CMP kinase 2: A novel nucleoside monophosphate kinase localized in mitochondria.
J Biol Chem. 2007 Nov 13; [Epub ahead of print]
PMID: 17999954 [PubMed - as supplied by publisher]
5:
The
Activating Killer Cell Immunoglobulin-Like Receptors as Important
Determinants of Acute Graft-Versus Host Disease in Hematopoietic Stem
Cell Transplantation for Acute Myelogenous Leukemia.
Activating Killer Cell Immunoglobulin-Like Receptors as Important
Determinants of Acute Graft-Versus Host Disease in Hematopoietic Stem
Cell Transplantation for Acute Myelogenous Leukemia.
Transplantation. 2007 Nov 15;84(9):1082-1091.
PMID: 17998861 [PubMed - as supplied by publisher]
6:
Rac
Guanosine Triphosphatases Represent Integrating Molecular Therapeutic
Targets for BCR-ABL-Induced Myeloproliferative Disease.
Guanosine Triphosphatases Represent Integrating Molecular Therapeutic
Targets for BCR-ABL-Induced Myeloproliferative Disease.
Cancer Cell. 2007 Nov;12(5):467-78.
PMID: 17996650 [PubMed - in process]
7:
Management of imatinib-resistant CML patients.
Onkologie. 2007 Nov;30(11):574-80. Epub 2007 Oct 11.
PMID: 17992029 [PubMed - in process]
8:
A
Novel Gene, ANKRD28 on 3p25, Is Fused with NUP98 on 11p15 in a Cryptic
3-Way Translocation of t(3;5;11)(p25;q35;p15) in an Adult Patient with
Myelodysplastic Syndrome/Acute Myelogenous Leukemia.
Novel Gene, ANKRD28 on 3p25, Is Fused with NUP98 on 11p15 in a Cryptic
3-Way Translocation of t(3;5;11)(p25;q35;p15) in an Adult Patient with
Myelodysplastic Syndrome/Acute Myelogenous Leukemia.
Int J Hematol. 2007 Oct;86(3):238-45.
PMID: 17988990 [PubMed - in process]
9:
Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia.
Blood Cells Mol Dis. 2007 Nov 5; [Epub ahead of print]
PMID: 17988908 [PubMed - as supplied by publisher]
10:
[The
investigation of JAK2 V617F point mutation in myeloproliferative
disorders by allele-specific polymerase chain reaction in combination
with sequence analysis]
investigation of JAK2 V617F point mutation in myeloproliferative
disorders by allele-specific polymerase chain reaction in combination
with sequence analysis]
Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2109-12. Chinese.
PMID: 17988529 [PubMed - in process]
11:
A
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous leukemia.
complex translocation t(5;9;22) in Philadelphia cells involving the
short arm of chromosome 5 in a case of chronic myelogenous leukemia.
J Exp Clin Cancer Res. 2007 Sep;26(3):411-5.
PMID: 17987804 [PubMed - in process]
12:
Nilotinib therapy in chronic myelogenous leukemia.
Drugs Today (Barc). 2007 Oct;43(10):691-702.
PMID: 17987222 [PubMed - in process]
13:
Blockade
of MEK/ERK signaling enhances sunitinib-induced growth inhibition and
apoptosis of leukemia cells possessing activating mutations of the FLT3
gene.
of MEK/ERK signaling enhances sunitinib-induced growth inhibition and
apoptosis of leukemia cells possessing activating mutations of the FLT3
gene.
Leuk Res. 2007 Nov 3; [Epub ahead of print]
PMID: 17983653 [PubMed - as supplied by publisher]
14:
Transformation of polycythemia vera to chronic myelogenous leukemia.
Arch Pathol Lab Med. 2007 Nov;131(11):1719-24.
PMID: 17979493 [PubMed - in process]
15:
Host immunosurveillance controls tumor growth via IFN regulatory factor-8 dependent mechanisms.
Cancer Res. 2007 Nov 1;67(21):10406-16.
PMID: 17974984 [PubMed - in process]
16:
Combination
therapy of an anticancer drug with the FNIII14 peptide of fibronectin
effectively overcomes cell adhesion-mediated drug resistance of acute
myelogenous leukemia.
therapy of an anticancer drug with the FNIII14 peptide of fibronectin
effectively overcomes cell adhesion-mediated drug resistance of acute
myelogenous leukemia.
Leukemia. 2007 Nov 1; [Epub ahead of print]
PMID: 17972943 [PubMed - as supplied by publisher]
17:
Intracerebral granulocytic sarcoma.
J Neurosci Nurs. 2007 Oct;39(5):297-304.
PMID: 17966297 [PubMed - in process]
18:
TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.
J Clin Invest. 2007 Nov 1;117(11):3283-3295.
PMID: 17960249 [PubMed - as supplied by publisher]
19:
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia.
Mol Cancer. 2007 Oct 25;6(1):67 [Epub ahead of print]
PMID: 17958915 [PubMed - as supplied by publisher]
20:
Molecular
diagnosis and monitoring in the clinical management of patients with
chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
diagnosis and monitoring in the clinical management of patients with
chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
Am J Hematol. 2007 Oct 23; [Epub ahead of print]
PMID: 17957805 [PubMed - as supplied by publisher]
Add A Comment
You must be logged in to post a comment.